Surgical Science Sweden AB (publ) (FRA:4P41)
Germany flag Germany · Delayed Price · Currency is EUR
2.580
-0.020 (-0.77%)
At close: Jan 30, 2026

FRA:4P41 Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
975.04884.09882.85802.54366.78104.8
Revenue Growth (YoY)
13.40%0.14%10.01%118.81%249.98%3.23%
Cost of Revenue
325.54286.19269.97271.02100.8416.44
Gross Profit
649.5597.9612.88531.52265.9488.36
Selling, General & Admin
299.44252.38240.02201.88117.2650.43
Research & Development
214.01196.11181.57172.7965.7116.57
Other Operating Expenses
4.585.092.14---
Operating Expenses
518.03453.58423.73374.66182.9767
Operating Income
131.47144.32189.15156.8682.9821.37
Interest Expense
-3.65-0.75-0.64-0.54-0.51-0.53
Interest & Investment Income
19.9623.9664.73--0.22
Currency Exchange Gain (Loss)
-39.93-4.2315.045.68-6.02-1.39
Other Non Operating Income (Expenses)
-3.89-5.21-0.0246.1718.06-
EBT Excluding Unusual Items
103.97158.09268.26208.1794.519.66
Merger & Restructuring Charges
-6.9----28.7-
Pretax Income
97.07158.09268.26208.1765.819.66
Income Tax Expense
27.2426.4534.2920.2-20.444.05
Net Income
69.83131.65233.97187.9786.2515.61
Net Income to Common
69.83131.65233.97187.9786.2515.61
Net Income Growth
-63.88%-43.73%24.47%117.95%452.66%23.88%
Shares Outstanding (Basic)
515151514234
Shares Outstanding (Diluted)
515151514334
Shares Change (YoY)
-0.01%0.17%0.05%19.32%24.14%18.32%
EPS (Basic)
1.372.584.593.702.030.45
EPS (Diluted)
1.372.584.593.692.020.45
EPS Growth
-63.88%-43.79%24.39%82.67%348.89%4.65%
Free Cash Flow
57.67131.12227.84120.1435.2122.83
Free Cash Flow Per Share
1.132.574.472.360.820.66
Gross Margin
66.61%67.63%69.42%66.23%72.51%84.32%
Operating Margin
13.48%16.32%21.43%19.55%22.62%20.39%
Profit Margin
7.16%14.89%26.50%23.42%23.52%14.89%
Free Cash Flow Margin
5.91%14.83%25.81%14.97%9.60%21.78%
EBITDA
166.43169.65212.15177.479927.8
EBITDA Margin
17.07%19.19%24.03%22.11%26.99%26.53%
D&A For EBITDA
34.9625.332320.6116.026.43
EBIT
131.47144.32189.15156.8682.9821.37
EBIT Margin
13.48%16.32%21.43%19.55%22.62%20.39%
Effective Tax Rate
28.06%16.73%12.78%9.70%-20.62%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.